» Articles » PMID: 14694518

Transition of High-grade Cervical Intraepithelial Neoplasia to Micro-invasive Carcinoma is Characterized by Integration of HPV 16/18 and Numerical Chromosome Abnormalities

Overview
Journal J Pathol
Specialty Pathology
Date 2003 Dec 25
PMID 14694518
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical intraepithelial neoplasia (CIN I, II, and III) and cases of CIN III associated with micro-invasive cervical carcinoma (CIN III & mCA) were analysed for evidence of episomal or integrated human papillomavirus (HPV) 16/18 DNA by fluorescence in situ hybridization (FISH). In parallel, numerical aberrations of chromosomes 1, 17, and X were determined in these lesions as indicators of genomic instability. HPV 16/18 DNA was present in 2 of 12 CIN I, 19 of 23 CIN II/III, and 10 of 12 CIN III & mCA. None of the CIN I and only two of the 19 HPV 16/18-positive solitary CIN II/III showed an integrated HPV pattern. However, all ten cases of HPV-positive CIN III & mCA showed this pattern. Transition of CIN II/III to CIN III & mCA therefore correlates strongly with viral integration (p<0.001). Chromosomal aberrations were detected in 23 of 31 HPV 16/18-positive lesions (14 solitary CIN I-III and nine CIN III & mCA) and 5 of 16 HPV-negative lesions. Nine of 21 HPV 16/18-positive solitary CIN I-III showed tetrasomy for all chromosomes tested, while trisomies for a single chromosome were seen in a further five of these HPV-positive lesions. In eight of ten HPV-positive CIN III & mCA, predominantly aneusomies and/or polysomies were detected. A significant correlation (p<0.02) was found between the chromosome copy number and the physical status of HPV, indicating that in its episomal form HPV induces genomic changes such as tetrasomies and single trisomies, while HPV integration correlates with aneusomies and polysomies, predominantly detected in CIN III & mCA. These data indicate that integration of HPV 16/18 DNA is a pivotal step in the transition of CIN to micro-invasive carcinoma.

Citing Articles

Analysis of HPV-16 viral load, integration status, and p16 expression in relation to EBV co-infection and cervical lesion severity.

Khamseh A, Farhadi A, Jalilvand S, Yarandi F, Izadi-Mood N, Ghorbani S Sci Rep. 2025; 15(1):8329.

PMID: 40065022 PMC: 11893773. DOI: 10.1038/s41598-025-93358-x.


Recent advances in immunotherapy for cervical cancer.

Ogasawara A, Hasegawa K Int J Clin Oncol. 2025; 30(3):434-448.

PMID: 39888529 PMC: 11842527. DOI: 10.1007/s10147-025-02699-0.


HPV and HCMV in Cervical Cancer: A Review of Their Co-Occurrence in Premalignant and Malignant Lesions.

Blanco R, Munoz J Viruses. 2024; 16(11).

PMID: 39599814 PMC: 11599080. DOI: 10.3390/v16111699.


Decoding Fujian's cervical HPV landscape: unmasking dominance of non-16/18 HR-HPV and tailoring prevention strategies at a large scale.

Zhang Y, Li H, You Q, Chen Y, Zhao Z, Chen J Front Public Health. 2024; 12:1357073.

PMID: 38903575 PMC: 11187235. DOI: 10.3389/fpubh.2024.1357073.


HPV DNA Integration at Actionable Cancer-Related Genes Loci in HPV-Associated Carcinomas.

Sastre-Garau X, Estrada-Virrueta L, Radvanyi F Cancers (Basel). 2024; 16(8).

PMID: 38672666 PMC: 11048798. DOI: 10.3390/cancers16081584.